losartan has been researched along with Chronic Primary Open Angle Glaucoma in 1 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costagliola, C | 1 |
| Verolino, M | 1 |
| De Rosa, ML | 1 |
| Iaccarino, G | 1 |
| Ciancaglini, M | 1 |
| Mastropasqua, L | 1 |
1 trial available for losartan and Chronic Primary Open Angle Glaucoma
| Article | Year |
|---|---|
Effect of oral losartan potassium administration on intraocular pressure in normotensive and glaucomatous human subjects.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Cross-Over Studies; Double-Blind Method; Female; Gla | 2000 |